Global Access Platform

One System for Reference Drugs, Emergencies & Shortages An integrated, compliant access platform where Reference Listed Drugs, Emergency Supply, and Shortage Response operate through a single regulated system 4 differentiated only by trigger and approval pathway.

One Integrated Platform, Three Critical Access Pathways GNH Global Access Regulatory Quality Traceability Speed Emergency Supply Rapid deployment for urgent needs Shortage Response Supply restoration and contingency plans Reference Listed Drugs Branded product regulatory pathway The GNH Global Access & Supply Integrity Platform unifies three distinct pharmaceutical access models under a single compliance framework, ensuring quality, speed, and regulatory adherence across all pathways.

Three Pillars, One Foundation Reference Listed Drugs Purpose: Comparator sourcing for generics, biosimilars, and bioequivalence studies Science-driven " Documented " Pre-registration Emergency & Unregistered Supply Purpose: Life-saving access where no local registration exists, with Ministry approval Time-bound " Medically justified " Regulator-approved Shortage-Driven Institutional Supply Purpose: Stock-out response ensuring continuity of care through controlled quantities Triggered by shortages " Controlled volumes

Shared Compliance Backbone

2026 Standard Unified Regulatory Infrastructure GMP-certified manufacturers All sources meet Good Manufacturing Practice standards Batch-level documentation Certificate of Pharmaceutical Product (CPP) and Certificate of Analysis (CoA) for every batch WHO-GDP logistics Temperature-controlled, validated cold chain distribution Serialisation & track-and-trace Real-time visibility from source to patient

Global Regulatory Integration EU Falsified Medicines Directive Full compliance with EU FMD serialisation requirements, ensuring product authenticity and patient safety across European markets through verified packaging systems. Russia Chestny ZNAK Integrated with Russian national track-and-trace mandate, providing complete product lifecycle visibility and counterfeit prevention through mandatory marking. Audit-Ready Documentation Comprehensive digital records maintained for regulatory inspection, ensuring transparency and compliance verification at any point in the supply chain.

Differentiation by Trigger, Not by System

  1. Reference Listed Drugs Triggered by pre-registration research needs " Approved through scientific documentation protocols
  2. Emergency Supply Triggered by urgent medical necessity " Approved through Ministry or Hospital emergency pathways
  3. Shortage Response Triggered by stock-outs or supply disruptions " Approved through institutional procurement channels

The Executive Imperative All three use cases run on the same regulated, auditable supply chain 4 only the trigger and approval pathway differ. Single Platform One infrastructure, one quality system, one compliance framework Multiple Pathways Flexible approval routes adapted to clinical urgency and regulatory context Uncompromising Standards 2026-ready compliance across all access models